Wednesday 14 October 2026
Export ALHC’s income statement to Excel — free account
Alignment Healthcare, Inc.
ALHC Healthcare Healthcare Plans
Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024. In the quarter to June 2026, revenue grew 31.6%, EPS grew 125.0%, free cash flow fell 229.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
8.30
0.21
+2.60%
Follow ALHC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 7 | 8 |
| (15.00%) | (0.52%) | 12.54% | 20.04% | ||
| (2.32%) | (0.08%) | 1.84% | 3.57% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(4.72%) | (0.16%) | 4.09% | 7.49% | |
Average Days of Receivables |
22.06 | 23.41 | 23.81 | 23.67 | |
Free Cash Flow per Share |
0.76 | 0.57 | 1.10 | 0.86 | |
Free Cash Flow |
150.63 | 113.22 | 226.18 | 177.51 | |
Capital Expenditures |
(30.96) | (26.71) | (25.82) | (28.03) | |
| Other line items | |||||
Cash ROIC |
13.35% | 10.23% | 18.00% | 13.75% | |
Accounts Receivable Turnover |
20.28 | 19.40 | 17.31 | 15.79 | |
Accounts Payable Turnover |
7.20 | 8.44 | 6.69 | 7.08 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
64.49 | 53.57 | 67.57 | 58.82 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.18 | 0.02 | 0.00 | 0.05 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.54% | 11.23% | 10.82% | 10.66% | |
Share Based Compensation of Revenue |
1.79% | 1.57% | 1.38% | 1.34% | |
Interest Coverage |
0.14 | 0.93 | 2.24 | 3.39 | |
Operating CF/Net income |
(8.73) | (193.27) | 12.72 | 5.05 | |
Depreciation/Fixed assets |
0.44 | 0.48 | 0.49 | 0.49 | |
Capex/Depreciation |
(1.05) | (0.86) | (0.82) | (0.86) | |
Revenue per Share |
18.27 | 19.94 | 20.73 | 22.06 | |
Operating CF per Share |
0.91 | 0.71 | 1.23 | 0.99 | |
Capex per Share |
(0.16) | (0.13) | (0.13) | (0.14) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates